Preliminary Study Offers a Clue for Diagnosing CTE in Living People

A preliminary study has identified a potential clue that could eventually help doctors recognize chronic traumatic encephalopathy (CTE) in living people. The finding addresses a central challenge in CTE research: the disease can currently be confirmed only by examining brain tissue after death. Source 1

The result remains an early research signal, not an approved clinical test. Available reporting does not identify the specific biomarker, imaging method, laboratory technique, sample size, study population, or diagnostic performance. Source 3

What Is CTE?

CTE is a progressive brain disease associated with repeated head impacts. Exposure can occur in contact sports, military service, certain occupations, and other situations involving repeated blows or jolts to the head.

Repeated impacts do not always cause a diagnosed concussion. A person may experience many impacts without losing consciousness or seeking medical care. However, exposure history alone is not a diagnosis. Researchers are still studying why some people develop CTE-related changes while others with similar exposure histories do not.

Possible symptoms include:

• Memory problems.
• Difficulty concentrating.
• Impaired judgment.
• Irritability or impulsivity.
• Depression and other mood changes.
• Behavioral changes.
• Balance or movement problems.

These symptoms are nonspecific. Depression, anxiety, post-traumatic stress disorder, sleep disorders, chronic pain, substance use, medication effects, aging, and other neurological diseases can cause similar problems.

Why CTE Is Difficult to Diagnose During Life

Symptoms and a history of repeated head impacts can raise clinical concern, but neither can confirm CTE. Definitive confirmation currently depends on neuropathological examination of brain tissue after death. Source 5

A reliable living diagnostic tool could support earlier evaluation, improve research enrollment, and help clinicians distinguish CTE-related changes from other causes of cognitive, psychiatric, and movement symptoms.

What the Preliminary Study Reported

Available reports describe a potential biological clue that may help identify CTE in living patients. They do not establish that doctors can use the finding to make a definitive diagnosis today. Source 1

The supplied source summaries do not provide enough information to evaluate the study fully. They do not identify the researchers, institution, publication, number of participants, sample type, testing method, measured outcome, sensitivity, specificity, comparison groups, or independent replication.

These details determine whether a finding is likely to work in general medical practice. A signal identified in a small, highly selected research group may not perform similarly in a broader population. A test that detects general brain injury may also fail to distinguish CTE from other diseases.

Early findings require replication because results can be affected by small sample sizes, selection bias, equipment differences, laboratory variation, unrecognized medical conditions, or chance. Independent teams should test the same clue in larger and more diverse groups.

What Would Make a CTE Test Clinically Useful?

A useful test would need strong sensitivity, meaning it correctly identifies people with the disease, and strong specificity, meaning it correctly excludes people without it. Low sensitivity can produce false-negative results, while low specificity can cause false-positive results, distress, inappropriate treatment, and inaccurate medical records.

Researchers would also need to compare living test results with postmortem brain findings. This comparison could show whether the test detects the characteristic pathology associated with CTE rather than a general response to injury, aging, psychiatric illness, or another neurological condition.

Validation should include diverse groups, such as:

• Athletes from different sports.
• Former athletes and non-athletes.
• Military veterans.
• People with and without diagnosed concussions.
• People with neurological or psychiatric conditions.
• Different ages and sexes.

The test would also need affordable access, clear interpretation, reproducible results, acceptable risks, regulatory review, and professional guidance on when to order it and how to act on the results.

Potential Effects on Care and Research

A validated test could help clinicians investigate symptoms during a patient’s lifetime. It would likely be used alongside medical history, neurological examination, cognitive testing, psychiatric assessment, and other diagnostic procedures rather than replacing them.

Stronger diagnostic evidence could help patients and families plan care, address safety concerns, and coordinate neurological, psychiatric, and rehabilitation services. It could also improve clinical trials by helping researchers identify participants, track biological progression, and measure treatment responses.

However, diagnostic information could raise concerns involving emotional health, insurance, employment, finances, and stigma. Counseling would be important, especially if results were uncertain or no disease-modifying treatment existed.

A diagnostic clue is not automatically a treatment target. Separate studies would be needed to show that any therapy is safe and effective.

What the Finding Does Not Mean

• It does not establish an available clinical test for CTE.
• It does not prove that every symptom after head injury is caused by CTE.
• It does not establish a treatment or cure.
• It does not show that exposure history can predict an individual’s future with certainty.

People should not diagnose themselves based on a news report, a history of sports participation, or a single symptom.

What Researchers Need to Study Next

Researchers need larger independent studies, long-term follow-up, comparisons with other neurological and psychiatric conditions, standardized testing protocols, and continued postmortem validation. They must determine whether the clue remains stable, changes as symptoms progress, predicts later disease, or responds to interventions.

News reports and research publications should distinguish an association from causation, a research signal from a diagnostic test, exposure risk from confirmed disease, and preliminary evidence from clinical consensus.

What People Concerned About CTE Can Do Now

People concerned about CTE should seek a comprehensive evaluation from a qualified health professional, such as a neurologist, neuropsychologist, psychiatrist, or primary-care clinician with relevant experience.

Bring information about:

• Previous head injuries.
• Sports, military, or occupational exposure.
• Cognitive, mood, behavioral, or movement symptoms.
• Medications and substance use.
• Sleep problems.
• Mental-health history.
• Other medical conditions.

Clinicians can evaluate symptoms and identify treatable conditions even when CTE cannot be confirmed during life. Reducing further head-impact exposure should also be discussed with a medical professional. Individual decisions about work, sports, or other activities require clinical assessment.

Conclusion

The preliminary study represents progress toward a living diagnostic approach for CTE. It identifies a potential clue that could eventually help researchers detect disease-related changes before death, but the available reports do not provide enough technical information to judge its accuracy or clinical readiness. Source 5

Larger studies, independent replication, comparisons with other conditions, long-term follow-up, and postmortem validation are needed. A definitive diagnosis of CTE during life remains a future possibility, not a current clinical reality.

Frequently Asked Questions

Can CTE be diagnosed in a living person?

Definitive confirmation currently requires postmortem examination of brain tissue. A preliminary biomarker may support future diagnosis, but it is not automatically clinically validated.

What is the new CTE diagnostic clue?

The available summaries identify only a potential clue. They do not provide enough verified information to name or explain the specific biomarker, imaging method, laboratory test, or measured outcome.

Does a history of repeated concussions mean someone has CTE?

No. Repeated head impacts may be associated with risk, but exposure history does not confirm CTE. Symptoms can have many other causes and require professional evaluation.

What symptoms may be associated with CTE?

Possible symptoms include changes in memory, thinking, mood, behavior, judgment, balance, or movement. These symptoms are nonspecific and do not establish a diagnosis.

When could a living CTE test become available?

No reliable timeline can be determined from a preliminary finding. Researchers must establish accuracy, compare the test with other conditions, validate it against neuropathology, and obtain regulatory and clinical acceptance.

What should someone do if they are worried about CTE?

Seek a comprehensive evaluation from a qualified health professional. Bring a detailed history of head impacts and current symptoms, while also considering treatable neurological, psychiatric, sleep, and medical conditions.